1
项与 rgp120/HIV-1 SF-2 vaccine(Chiron) 相关的临床试验A Phase I Trial to Evaluate the HIV-1 SF-2 Recombinant p24 Subunit Vaccine [Chiron Vaccines] Administered as a Novel Boost in "Prime-Boost" Vaccination Regimens With ALVAC-HIV vCP205 [Pasteur Merieux Connaught] and HIV-1 SF-2 rgp120 in MF59 [Chiron Vaccines]
The purpose of this study is to test three experimental HIV vaccines. This study will look at whether it is safe to give these vaccines together and how the immune system responds to the vaccines.
There are a number of studies being performed to test HIV vaccines. The vaccines that seem to be the most promising are canarypox vaccines, known as ALVAC vaccines. The three experimental HIV vaccines used in this study are called ALVAC-HIV vCP205, HIV-1 SF-2 p24, and HIV-1 SF-2 rgp120. The HIV-1 SF-2 p24 and HIV-1 SF-2 rgp120 vaccines are mixed with an adjuvant, which is a substance that increases immune response.
100 项与 rgp120/HIV-1 SF-2 vaccine(Chiron) 相关的临床结果
100 项与 rgp120/HIV-1 SF-2 vaccine(Chiron) 相关的转化医学
100 项与 rgp120/HIV-1 SF-2 vaccine(Chiron) 相关的专利(医药)
100 项与 rgp120/HIV-1 SF-2 vaccine(Chiron) 相关的药物交易